Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Change in Receivables: 2011-2025

Historic Change in Receivables for Sonoma Pharmaceuticals (SNOA) over the last 14 years, with Mar 2025 value amounting to -$434,000.

  • Sonoma Pharmaceuticals' Change in Receivables fell 1413.59% to -$1.4 million in Q1 2013 from the same period last year, while for Mar 2013 it was -$411,000, marking a year-over-year decrease of 350.61%. This contributed to the annual value of -$434,000 for FY2025, which is 288.70% down from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Change in Receivables stood at -$434,000 for FY2025, which was down 288.70% from $230,000 recorded in FY2024.
  • Sonoma Pharmaceuticals' 5-year Change in Receivables high stood at $230,000 for FY2024, and its period low was -$2.6 million during FY2021.
  • Its 3-year average for Change in Receivables is -$66,667, with a median of $4,000 in 2023.
  • Per our database at Business Quant, Sonoma Pharmaceuticals' Change in Receivables skyrocketed by 5,650.00% in 2024 and then tumbled by 288.70% in 2025.
  • Over the past 5 years, Sonoma Pharmaceuticals' Change in Receivables (MRY) stood at -$2.6 million in 2021, then grew by 24.42% to -$2.0 million in 2022, then soared by 100.20% to $4,000 in 2023, then surged by 5,650.00% to $230,000 in 2024, then crashed by 288.70% to -$434,000 in 2025.
  • Its last three reported values are -$434,000 in FY2025, $230,000 for FY2024, and $4,000 during FY2023.